| Literature DB >> 30875753 |
Rodrigo Torres-Castro1,2, Jordi Vilaró3, Joan-Daniel Martí4, Onintza Garmendia5, Elena Gimeno-Santos6,7, Bárbara Romano-Andrioni8, Cristina Embid9, Josep M Montserrat10.
Abstract
Physical activity is associated with a decreased prevalence of obstructive sleep apnea and improved sleep efficiency. Studies on the effects of a comprehensive exercise program in a community setting remain limited. Our objective was to investigate the effects of a combined physical and oropharyngeal exercise program on the apnea-hypopnea index in patients with moderate to severe obstructive sleep apnea. This was a randomized clinical trial where the intervention group followed an eight-week urban-walking program, oropharyngeal exercises, and diet and sleep recommendations. The control group followed diet and sleep recommendations. A total of 33 patients were enrolled and randomized and, finally, 27 patients were included in the study (IG, 14; CG, 13) Obstructive sleep apnea patients were analyzed with a median age of 67 (52⁻74) and median apnea-hypopnea index of 32 events/h (25⁻41). The apnea-hypopnea index did not differ between groups pre- and post-intervention. However, in intervention patients younger than 60 (n = 6) a reduction of the apnea-hypopnea index from 29.5 (21.8⁻48.3) to 15.5 (11⁻34) events/h (p = 0.028) was observed. While a comprehensive multimodal program does not modify the apnea-hypopnea index, it could reduce body weight and increase the walking distance of patients with moderate to severe obstructive sleep apnea. Patients younger than 60 may also present a decreased apnea-hypopnea index after intervention.Entities:
Keywords: apnea-hypopnea syndrome; oropharyngeal exercises; physical training; urban-walking program
Year: 2019 PMID: 30875753 PMCID: PMC6463021 DOI: 10.3390/jcm8030361
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1CONSORT flow chart of participants of study.
Baseline characteristics of study participants.
| Control ( | Intervention ( | ||
|---|---|---|---|
| Anthropometric data | |||
| Age, years | 67 (53–74.5) | 64.5 (51.8–74) | 0.793 |
| Males, % | 57.1 | 53.8 | |
| Body weight, Kg | 82 (70–87.5) | 86 (80.5–90.5) | 0.116 |
| Height, cm | 166.6 ± 9.3 | 163.8 ± 8.3 | 0.458 |
| BMI, Kg/m2 | 27.1 (25.1–35.9) | 31.3 (27.5–35.0) | 0.375 |
| Neck circumference, cm | 38 (37–41.5) | 40 (37–41.5) | 0.616 |
| Waist circumference, cm | 107 (97–114.5) | 108.5 (102.5–114) | 0.519 |
| Hip circumference, cm | 96 (91.5–107.5) | 97 (93.5–109) | 0.720 |
| Polysomnographic data | |||
| AHI/h | 37 (25.5–43.5) | 30.5 (22.5–41.3) | 0.325 |
| CT90 | 22 (3.5–28.5) | 12 (4–21.3) | 0.239 |
| ODI/h | 34 (29.5–44.5) | 30 (22.3–39.8) | 0.280 |
| Exercise Capacity | |||
| 6MWD, m | 529.8 ± 102.7 | 548.2 ± 83.9 | 0.550 |
| Questionnaires | |||
| ESS | 8 (6.5–11) | 8 (3–13) | 0.756 |
| QSQ | |||
| Total score | 172 (133–186.5) | 180.5 (151.3–200) | 0.430 |
| Daytime Sleepiness | 36 (29.5–37.5) | 38 (29.3–40.3) | 0.488 |
| Diurnal symptoms | 50 (43.5–62) | 59.5 (45–66) | 0.430 |
| Nocturnal symptoms | 35 (26.5–38) | 35 (29.8–42.3) | 0.430 |
| Emotions | 30 (19.5–31) | 27 (21.8–29.3) | 0.375 |
| Social interactions | 23 (17–24) | 23 (21–25) | 0.583 |
| HAD | |||
| Total score | 14 (6–23.5) | 9 (3.8–18.8) | 0.550 |
| Anxiety | 8 (6–12.5) | 6 (2.8–10) | 0.325 |
| Depression | 6 (1–9) | 2.5 (1–8) | 0.720 |
Abbreviations: BMI: body mass index, AHI: Apnea Hypopnea Index, CT90: cumulative percentages of time spent at saturations below 90%, ODI: oxygen desaturation index, 6MWD: Six-minute walking distance, ESS: Epworth Sleepiness Scale; QSQ: Quebec Sleep Questionnaire, and HAD: Hospital Anxiety and Depression Score. Values are expressed as the mean ± SD if data is normally distributed or as the median (P25–P75) if data distribution is skewed.
Changes between variables according to intervention groups.
| Intervention Group ( | Control Group ( | |||||
|---|---|---|---|---|---|---|
| Baseline | After 8 Weeks | Baseline | After 8 Weeks | |||
| Anthropometric data | ||||||
| Body weight, Kg | 86 (80.5–90.5) | 85.3 (77–88.3) | 0.003 | 82 (70–87.5) | 81 (70–86.5) | 0.233 |
| BMI, Kg/m2 | 31.3 (27.5–35) | 30.2 (27.3–34.7) | 0.003 | 27.1 (25.1–35.9) | 27.1 (25.1–35.6) | 0.237 |
| Neck circumference, cm | 40 (37–41.5) | 38.8 (37.4–40.5) | 0.056 | 38 (37–41.5) | 40 (36.3–41.3) | 0.878 |
| Waist circumference, cm | 108.5 (102–114) | 107 (99–113.5) | 0.022 | 107 (97–114.5) | 106 (99.5–115) | 0.791 |
| Hip circumference, cm | 97 (93.5–109) | 98.5 (92.8–108.8) | 0.514 | 96 (91.5–107.5) | 95 (92.3–106) | 0.150 |
| Polysomnographic data | ||||||
| AHI/h | 30.5 (22.5–41.3) | 34.5 (14.5–45) | 0.875 | 37 (25.5–43.5) | 43 (28–46) | 0.529 |
| CT90 | 12 (4–21.3) | 7 (3.8–23.3) | 0.423 | 22 (3.5–28.5) | 13 (5.6–25) | 0.625 |
| ODI/h | 30 (22.3–39.8) | 30.5 (14.8–45.3) | 0.780 | 34 (29.5–44.5) | 38 (25.5–44) | 0.944 |
| Exercise Capacity | ||||||
| 6MWD, m | 548.2 ± 83.9 | 567.1 ± 85.3 | 0.020 | 529.8 ± 102.7 | 519.8 ± 108.0 | 0.249 |
| Questionnaires | ||||||
| ESS | 8 (3–13) | 8 (4–10.3) | 0.634 | 8 (6.5–11) | 7 (6.5–10.5) | 0.500 |
| QSQ | ||||||
| Total score | 180.5 (151–200) | 186 (153.8–201) | 0.572 | 172 (133–186.5) | 176 (130–200) | 0.388 |
| Daytime Sleepiness | 38 (29.3–40.3) | 37 (34.3–40) | 0.422 | 36 (29.5–37.5) | 36 (29.5–39.5) | 0.916 |
| Diurnal symptoms | 59.5 (45–66) | 56 (48.5–61.3) | 0.889 | 50 (43.5–62) | 53 (36.5–63) | 0.937 |
| Nocturnal symptoms | 35 (29.8–42.3) | 39 (32.3–42.5) | 0.170 | 35 (26.5–38) | 35 (30–41.5) | 0.116 |
| Emotions | 27 (21.8–29.3) | 28.5 (24.5–30.5) | 0.169 | 30 (19.5–31) | 30 (19.5–32) | 0.641 |
| Social interactions | 23 (21–25) | 21.5 (18.8–24.3) | 0.431 | 23 (17–24) | 23 (19.5–25.5) | 0.372 |
| HAD | ||||||
| Total score | 9 (3.8–18.8) | 10 (5.8–15.6) | 0.783 | 14 (6–23.5) | 12 (6–24) | 0.350 |
| Anxiety | 6 (2.8–10) | 7.5 (4–9.3) | 0.916 | 8 (6–12.5) | 7 (4.5–12) | 0.126 |
| Depression | 2.5 (1–8) | 3 (1.8–6.5) | 0.587 | 6 (1–9) | 6 (1.5–11.5) | 0.142 |
Abbreviations. BMI: body mass index, AHI: Apnea Hypopnea Index, CT90: cumulative percentages of time spent at saturations below 90%, ODI: oxygen desaturation index, 6MWD: Six-minute walking distance, ESS: Epworth Sleepiness Scale; QSQ: Quebec Sleep Questionnaire, and HAD: Hospital Anxiety and Depression Score. * Intragroup comparison before and after using paired t-test for continuous variables and the Mann–Whitney U test if the distribution was skewed.
Figure 2The apnea-hypopnea index before (i.e., baseline) and after a comprehensive eight-week protocol in patients with obstructive sleep apnea. Intragroup comparison before and after using a Wilcoxon test for skewness distribution. Intergroup comparisons for differences between variables were assessed using the Mann-Whitney test for skewness distribution.
Effects of combined intervention, analyzed by age (i.e., younger or older than 60).
| Group < 60 years ( | Group > 60 years ( | |||||
|---|---|---|---|---|---|---|
| Baseline | After 8 Weeks | Baseline | After 8 Weeks | |||
| Anthropometric data | ||||||
| Body weight, kg | 90 (81.3–101.5) | 86.5 (77–100.5) | 0.042 | 84 (71.5–86.8) | 82.6 (71–86.6) | 0.027 |
| BMI, kg/m2 | 33.1 (28.7–37) | 32.1 (27.6–35.9) | 0.043 | 29.6 (25–34) | 29.3 (25–33.4) | 0.028 |
| Neck circumference, cm | 38.5 (35.8–40.3) | 38.8 (35.8–40) | 0.655 | 40.5 (37.8–44.5) | 38.5 (37.6–44.3) | 0.072 |
| Waist circumference, cm | 113 (102.3–125.8) | 113.5 (98.5–123.3) | 0.144 | 108 (100.3–109.8) | 106.5 (100.3–107.8) | 0.088 |
| Hip circumference, cm | 97 (88.8–111) | 92 (87.5–112.5) | 0.414 | 99.5 (95.5–113) | 101 (94.8–110.3) | 0.833 |
| Polysomnographic data | ||||||
| AHI/h | 29.5 (21.8–48.3) | 15.5 (11–34) | 0.028 | 31.5 (21–38.8) | 43.5 (24.8–48) | 0.017 |
| CT90 | 4.5 (3.8–10) | 4 (2.5–11) | 0.498 | 14.5 (11.5–21.8) | 16.5 (6–51) | 0.173 |
| ODI/h | 25 (15–35) | 15.5 (12.5–32.5) | 0.223 | 33 (25.8–43.3) | 41.5 (24.3–46.8) | 0.441 |
| Exercise capacity | ||||||
| 6MWD, m | 585.0 ± 63.0 | 597.8 ± 70.1 | 0.173 | 520.7 ± 90.6 | 544.0 ± 92.7 | 0.036 |
| Questionnaires | ||||||
| ESS | 9 (6.8–19) | 10.5 (4–19.5) | 0.666 | 6.5 (3–11.8) | 7.5 (2.3–8.8) | 0.523 |
| QSQ | ||||||
| Total score | 185.5 (150.8–201) | 171.5 (142.5–194.5) | 0.046 | 177 (136.3–200) | 186.5 (170–201) | 0.069 |
| Daytime Sleepiness | 38.5 (28–40.3) | 37.5 (25.8–40) | 0.074 | 35 (25.8–40.3) | 37 (35–41) | 0.058 |
| Diurnal symptoms | 61 (45–66) | 52 (45.8–62.5) | 0.223 | 56.5 (39.3–65.5) | 58.5 (49–61.8) | 0.233 |
| Nocturnal symptoms | 38 (32.3–44) | 38 (32.3–44.3) | 0.914 | 35 (25.3–38.3) | 40 (32–41.8) | 0.061 |
| Emotions | 26 (21.5–30) | 26.5 (20–30.3) | 0.683 | 27.5 (21.3–29.8) | 30 (26.3–31.5) | 0.040 |
| Social interactions | 23 (19.8–25.5) | 19 (13.8–23.5) | 0.116 | 23 (19–24.8) | 22.5 (20.3–24.8) | 0.526 |
| HAD | ||||||
| Total score | 9.5 (2.8–25) | 11 (7.8–24.3) | 0.236 | 9 (5–16) | 8 (5.3–15) | 1.000 |
| Anxiety | 8 (2–11.8) | 8 (6–11.8) | 0.750 | 5.5 (3.5–9.25) | 5 (4–9) | 0.932 |
| Depression | 1.5 (0.8–11.8) | 3 (1.8–11) | 0.285 | 3.5 (1.3–7) | 3 (1.3–6) | 0.829 |
Abbreviations. BMI: body mass index, AHI: Apnea Hypopnea Index, CT90: cumulative percentages of time spent at saturations below 90%, ODI: oxygen desaturation index, 6MWD: Six minute walking distance, ESS: Epworth Sleepiness Scale; QSQ: Quebec Sleep Questionnaire, and HAD: Hospital Anxiety and Depression Score. * Intragroup comparison before and after intervention using a paired t-test for continuous variables and a Mann–Whitney U test for skewed distributions.